Detalhe da pesquisa
1.
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
N Engl J Med
; 379(4): 327-340, 2018 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897841
2.
Comorbidities increase in-hospital mortality in dengue patients in Brazil.
Mem Inst Oswaldo Cruz
; 113(8): e180082, 2018 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043823
3.
Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine effectiveness.
Vaccine
; 41(41): 6105-6111, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661533
4.
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.
Pediatr Infect Dis J
; 40(9): 856-863, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117198
5.
Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
Vaccine
; 39(25): 3388-3396, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33992441
6.
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.
Pediatr Infect Dis J
; 40(8): 774-781, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250977
7.
Mortality among Hospitalized Dengue Patients with Comorbidities in Mexico, Brazil, and Colombia.
Am J Trop Med Hyg
; 105(1): 102-109, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970884
8.
Comorbidities increase in-hospital mortality in dengue patients in Brazil
Mem. Inst. Oswaldo Cruz
; 113(8): e180082, 2018. tab
Artigo
em Inglês
| LILACS | ID: biblio-1040600
9.
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children.
Arch Med Res
; 43(5): 402-5, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22868187
10.
Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?
Clin Vaccine Immunol
; 17(10): 1639-41, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20719986
11.
The safety and immunogenicity of influenza vaccine in children with asthma in Mexico.
Int J Infect Dis
; 13(4): 469-75, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19084453
12.
[Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico]. / Inmunogenicidad y tolerancia de una vacuna contra influenza, en una población mexicana mayor de 55 años de edad.
Salud Publica Mex
; 47(2): 155-62, 2005.
Artigo
em Espanhol
| MEDLINE | ID: mdl-15889641
13.
Inmunogenicidad y tolerancia de una vacuna contra influenza, en una población mexicana mayor de 55 años de edad / Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico
Salud pública Méx
; 47(2): 155-162, mar.-abr. 2005. tab, graf
Artigo
em Espanhol
| LILACS | ID: lil-415212